Results 21 to 30 of about 23,218 (270)
Journal of the Saudi Society of Agricultural Sciences, 2017 The influences of drought stress on the photosynthesis rate, the chlorophyll fluorescence parameters, the activity of protective enzymes of potato, and the biomass fresh weights of potato leaves at seedling stage were investigated, using two different ...
Jianhui Li +5 more
doaj +1 more source
PCSK4 (proprotein convertase subtilisin/kexin type 4) [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2015 Review on PCSK4 (proprotein convertase subtilisin/kexin type 4), with data on DNA, on the protein encoded, and where the gene is implicated.
Khatib, M, Demoures, B
openaire +2 more sources
A Sequential Optimization Calibration Algorithm for Near-Field Source Localization
Sensors, 2017 This paper considers the near-field source location problem for a nonuniform linear array (non-ULA) in the presence of sensor gain and phase errors. A sequential optimization calibration method is proposed to simultaneously estimate the gain and phase ...
Jingjing Li, Xianxiang Yu, Guolong Cui
doaj +1 more source
On Strengthening the Dissemination of Positive Chinese Traditional Culture in Colleges and Universities in the New Media Era [PDF]
SHS Web of Conferences, 2023 General Secretary Xi Jinping once profoundly pointed out that “Positive Chinese traditional culture is the root and soul of the everlasting Chinese nation”.1 However, the traditional communication mode of positive Chinese traditional culture is facing ...
Li Kexin
doaj +1 more source
Proprotein convertase subtilisin kexin 9 inhibitors: Current status and future directions
Journal of Clinical and Preventive Cardiology, 2017 The discovery of proprotein convertase subtilisin kexin 9 (PCSK9) has considerably changed the therapeutic options in the field of lipid management. PCSK9 reduces low-density lipoprotein receptor (LDLR) recycling, leading to a decrease of LDL cholesterol
JPS Sawhney, Saurabh Bagga
doaj +1 more source
Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients
JACC: Case Reports, 2020 Standard lipid-lowering therapies in solid organ transplantations pose challenges due to interactions with immunosuppressants. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of lipid-lowering therapies with ...
Bruce A. Warden, PharmD +5 more
doaj +1 more source
Frontiers in Immunology, 2023 BackgroundImmunogenic cell death (ICD) is a form of cell death that elicits immune responses against the antigens found in dead or dying tumor cells. Growing evidence implies that ICD plays a significant role in triggering antitumor immunity.
Yirui Kuang +8 more
doaj +1 more source
Proprotein convertase subtilisin/kexin type 9 and lipid metabolism [PDF]
Current Opinion in Lipidology, 2019 Purpose of review The purpose of this review is to highlight the recent findings of one of the most promising therapeutic targets in LDL cholesterol (LDL-C) management, proprotein convertase subtilisin/kexin type 9 (PCSK9).
Stefano, Spolitu +3 more
openaire +2 more sources
Proprotein Convertase Subtilisin/Kexin 9 Inhibitors
Journal of Cardiovascular Pharmacology and Therapeutics, 2014 Proprotein convertase subtilisin/kexin 9 (PCSK9) is part of the proteinase K subfamily of subtilases and plays a key role in lipid metabolism. It increases degradation of the low-density lipoprotein receptor (LDL-R), modulates cholesterol metabolism and transport, and contributes to the production of apolipoprotein B (apoB) in intestinal cells ...
Simona, Dragan +2 more
openaire +2 more sources
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors [PDF]
Clinical Research in Cardiology Supplements, 2019 Lipoprotein(a) (Lp(a)) is an internationally accepted independent atherogenic risk factor. Details about its synthesis, many aspects of composition and clearance from the bloodstream are still unknown. LDL receptor (LDLR) (and probably other receptors) play a role in the elimination of Lp(a) particles.
Julius, U +4 more
openaire +2 more sources